just now
Mitrade has announced a global sponsorship of the World Snooker Tour (WST) for the 2026/27 season, aligning the trading platform's brand with a sport built on composure and sustained focus under pressure.
The partnership arrives as Mitrade's growth accelerates. Since January 2026, the group reports that active trading clients increased 54% year on year, while the number of trades rose 79% and total lots traded grew 148%.
The WST sponsorship provides Mitrade with a platform to engage with its growing community of traders and snooker fans and to strengthen brand awareness across multiple markets.
Kevin Lai, Vice President, Mitrade Group said:
"The World Snooker Tour is a prestigious platform with a global following, and we are proud to support its reach. The sport reflects qualities we value. Thoughtful decision-making, discipline, and respect for risk. It reinforces our responsible growth and commitment to helping traders understand markets, and we look forward to a relationship with WST's community."
Peter Wright, Chief Commercial Officer, WST
Peter Wright, Chief Commercial Officer, WST commented:
"We are delighted to welcome Mitrade to the World Snooker Tour. This is a significant partnership with a dynamic global brand, and we are excited about working together across our European events. We look forward to seeing Mitrade become a prominent part of the World Snooker Tour throughout the season."
Mitrade's involvement with WST kicks off at the British Open in Cheltenham on 31 August 2026.
Mitrade is a globally recognised, award-winning CFD trading platform licensed under the UAE's CMA (20200000397), South Africa's FSCA (FSP 54842), the Cayman Islands' CIMA (SIB1612446), Mauritius's FSC (GB20025791), Australia's ASIC (AFSL398528), and Cyprus's CySEC (CIF438/23).
Mitrade connects 7M+ traders to 1,000+ OTC derivatives, including indices, forex, commodities, ETFs, and shares, with a platform designed to provide fast trade execution, competitive spreads, and a user-friendly interface accessible across multiple devices.
OTC derivatives are a leveraged product and can result in the loss of your entire capital. Trading OTC derivatives may not be suitable for everyone. Please consider the product sheet, risk disclosure statement and client agreement before using the services and ensure that you understand the risks involved.
Found this interesting? Become a member of LiquidityFinder and get daily industry news direct to your inbox — join here.
